WSC 2025 | Plans for upcoming trials to evaluate endovascular thrombectomy for CVT
Ronen Leker, MD, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, discusses plans for upcoming trials to evaluate endovascular thrombectomy (EVT) in cerebral venous thrombosis (CVT). Prof. Leker highlights plans by several different groups, stating that the methodology for the trial is still being considered. This interview took place at the 17th World Stroke Congress (WSC) in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
There are ideas of forming a trial. I am part of the international CSVT consortium. And in the consortium, which incorporates medical centers from all over the world, it’s a global initiative, we are looking to start such a study and we are talking to our North American colleagues who are also thinking about doing such a study and a French group who’s also thinking about doing such a study...
There are ideas of forming a trial. I am part of the international CSVT consortium. And in the consortium, which incorporates medical centers from all over the world, it’s a global initiative, we are looking to start such a study and we are talking to our North American colleagues who are also thinking about doing such a study and a French group who’s also thinking about doing such a study. So we’re kind of thinking what would be the best methodology for this kind of study. Would it be a randomized study or should it be a global initiative, and not a study, but a registry instead of doing a randomized study, which will take a lot of effort and a lot of time to do. And we’re also thinking about the inclusion exclusion criteria. We’re also thinking about treatment strategies with the EVT, which devices to use, which devices to ban from using. And we have formed discussion forums within the consortium. And we hope that we can start the trial within the next year or maybe two. And hopefully, if this trial is going to show positive effects of EVT in terms of earlier recanalization and in terms of increased survival and in terms of more favorable outcomes. Also taking into account importantly patient-reported outcome measure prompts and obviously we think that that might change future guidelines as to the indications and the use of EVT in patients with CSVT.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
